Cumulative incidence curves.

Baseline characteristics and the number of transurethral procedures during 2 and 5 years of follow-up for the cohort of non-muscle invasive bladder cancer (NMIBC) patients and their matched comparison cohort.

Lars Holmberg (73013)
Oskar Hagberg (5069237)
Christel Häggström (276145)
Truls Gårdmark (10099132)
Viveka Ströck (10099141)
Firas Aljabery (5594660)
Staffan Jahnson (10099135)
Abolfazl Hosseini (1370439)
Tomas Jerlström (10046416)
Amir Sherif (5474768)
Karin Söderkvist (11189729)
Anders Ullén (5997569)
Mats Enlund (13851132)
Fredrik Liedberg (39980)
Per-Uno Malmström (573918)

September 2022

Baseline characteristics and the number of transurethral procedures during 2 and 5 years of follow-u...

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer - Fig 3

Bum Sik Tae (4688254)
Chang Wook Jeong (423166)
Cheol Kwak (474070)
Hyeon Hoe Kim (474071)
Kyung Chul Moon (626525)
Ja Hyeon Ku (474072)

December 2017

(A) Kaplan-Meier curves of progression-free survival (RFS) in patients with intravesical treatmen...

Predicting recurrence and progression in non-muscle-invasive bladder cancer using European organization of research and treatment of cancer risk tables.

Ather, M Hammad
Zaidi, Masooma

July 2009

Introduction:We determined the recurrence and progression at 1 year in Patients with non-muscle-inva...

Expression of XPF and XPC bladder cancer recurrence.

Jianhong Qiu (678707)
Xiangwei Wang (145471)
Xiaodong Meng (678708)
Yan Zheng (61178)
Gang Li (34549)
Jiyao Ma (678709)
Gang Ye (318792)
Yong Li (15029)
Jie Li (15030)

December 2014

Kaplan-Meier Curves using log rank tests for the recurrence of bladder cancer in patients. (a) Th...

8 Central European Journal of Urology

August 2016

One of the most burning problems of modern urology still remains the treatment of bladder cancer, wh...

International Biometric Society Modelling the Effect of Accumulating Recurrences and Progression in Bladder Cancer Data

Gregorio Rubio
Juan R. González

January 2015

Multiple sequential recurrences are one of the most important characteristics of superficial transit...

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Sylvester, R.J.
Meijden, A.P. van der
Oosterlinck, W.
Witjes, J.A.
Bouffioux, C.
Denis, L.
Newling, D.W.W.
Kurth, K.H.

January 2006

Contains fulltext : 49254.pdf (publisher's version ) (Closed access

Univariate analysis of clinical characteristic influence on recurrence in 219 patients with bladder cancer.

Jianhong Qiu (678707)
Xiangwei Wang (145471)
Xiaodong Meng (678708)
Yan Zheng (61178)
Gang Li (34549)
Jiyao Ma (678709)
Gang Ye (318792)
Yong Li (15029)
Jie Li (15030)

December 2014

Univariate analysis of clinical characteristic influence on recurrence in 219 patients with bladd...

The smoking status and bladder cancer recurrence.

Jianhong Qiu (678707)
Xiangwei Wang (145471)
Xiaodong Meng (678708)
Yan Zheng (61178)
Gang Li (34549)
Jiyao Ma (678709)
Gang Ye (318792)
Yong Li (15029)
Jie Li (15030)

December 2014

Kaplan-Meier Curves using log rank tests for the recurrence of bladder cancer in patients. (a) Th...

Recurrence and Progression Rate of High Grade Ta Bladder Cancer: 5-Year Follow up Results

Muhammet Kilinc

March 2014

Aim: The aim of the present study to evaluate recurrence and progression rates and success of BCG th...

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer - Fig 1

Bum Sik Tae (4688254)
Chang Wook Jeong (423166)
Cheol Kwak (474070)
Hyeon Hoe Kim (474071)
Kyung Chul Moon (626525)
Ja Hyeon Ku (474072)

December 2017

(A) Kaplan-Meier curves of recurrence-free survival (RFS) in patients with stage T1 (green) and o...

Stratifying risk for multiple, recurrent, and large (≥3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer

Jungyo Suh
Jae Hyun Jung
Cheol Kwak
Hyeon Hoe Kim
Ja Hyeon Ku

July 2021

Purpose: The current stratification of risk groups regarding recurrence and progression of non-muscl...

Re-examination of the Natural History of High-grade T1 Bladder Cancer using a Large Contemporary Cohort

Daniel J. Canter
Louis M. Revenig
Zachary L. Smith
Ryan W. Dobbs
S. Bruce Malkowicz
Muta M. Issa
Thomas J. Guzzo

April 2014

IntroductionHigh-grade T1 (HGT1) bladder cancer represents a clinical challenge in that the urologis...

Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score

Marie Simon (6407015)
Pierre-Olivier Bosset (6407018)
Mathieu Rouanne (3497495)
Simone Benhamou (111834)
Camelia Radulescu (6407021)
Vincent Molinié (5651248)
Yann Neuzillet (111802)
Xavier Paoletti (111804)
Thierry Lebret (111837)

February 2019

AimTo assess the prognostic value of multiple recurrences on the risk of progression in a large coho...

Aspects of Recurrence and Progression in Ta/T1 Urinary Bladder Cancer

Jancke, Georg

January 2013

Aims: To evaluate different aspects of recurrence and, when appropriate, progression in primary Ta/T...

Baseline characteristics and the number of transurethral procedures during 2 and 5 years of follow-up for the cohort of non-muscle invasive bladder cancer (NMIBC) patients and their matched comparison cohort.

Lars Holmberg (73013)
Oskar Hagberg (5069237)
Christel Häggström (276145)
Truls Gårdmark (10099132)
Viveka Ströck (10099141)
Firas Aljabery (5594660)
Staffan Jahnson (10099135)
Abolfazl Hosseini (1370439)
Tomas Jerlström (10046416)
Amir Sherif (5474768)
Karin Söderkvist (11189729)
Anders Ullén (5997569)
Mats Enlund (13851132)
Fredrik Liedberg (39980)
Per-Uno Malmström (573918)

September 2022

Baseline characteristics and the number of transurethral procedures during 2 and 5 years of follow-u...

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer - Fig 3

Bum Sik Tae (4688254)
Chang Wook Jeong (423166)
Cheol Kwak (474070)
Hyeon Hoe Kim (474071)
Kyung Chul Moon (626525)
Ja Hyeon Ku (474072)

December 2017

(A) Kaplan-Meier curves of progression-free survival (RFS) in patients with intravesical treatmen...

Predicting recurrence and progression in non-muscle-invasive bladder cancer using European organization of research and treatment of cancer risk tables.

Ather, M Hammad
Zaidi, Masooma

July 2009

Introduction:We determined the recurrence and progression at 1 year in Patients with non-muscle-inva...

Expression of XPF and XPC bladder cancer recurrence.

Jianhong Qiu (678707)
Xiangwei Wang (145471)
Xiaodong Meng (678708)
Yan Zheng (61178)
Gang Li (34549)
Jiyao Ma (678709)
Gang Ye (318792)
Yong Li (15029)
Jie Li (15030)

December 2014

Kaplan-Meier Curves using log rank tests for the recurrence of bladder cancer in patients. (a) Th...

8 Central European Journal of Urology

August 2016

One of the most burning problems of modern urology still remains the treatment of bladder cancer, wh...

International Biometric Society Modelling the Effect of Accumulating Recurrences and Progression in Bladder Cancer Data

Gregorio Rubio
Juan R. González

January 2015

Multiple sequential recurrences are one of the most important characteristics of superficial transit...

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Sylvester, R.J.
Meijden, A.P. van der
Oosterlinck, W.
Witjes, J.A.
Bouffioux, C.
Denis, L.
Newling, D.W.W.
Kurth, K.H.

January 2006

Contains fulltext : 49254.pdf (publisher's version ) (Closed access

Univariate analysis of clinical characteristic influence on recurrence in 219 patients with bladder cancer.

Jianhong Qiu (678707)
Xiangwei Wang (145471)
Xiaodong Meng (678708)
Yan Zheng (61178)
Gang Li (34549)
Jiyao Ma (678709)
Gang Ye (318792)
Yong Li (15029)
Jie Li (15030)

December 2014

Univariate analysis of clinical characteristic influence on recurrence in 219 patients with bladd...

The smoking status and bladder cancer recurrence.

Jianhong Qiu (678707)
Xiangwei Wang (145471)
Xiaodong Meng (678708)
Yan Zheng (61178)
Gang Li (34549)
Jiyao Ma (678709)
Gang Ye (318792)
Yong Li (15029)
Jie Li (15030)

December 2014

Kaplan-Meier Curves using log rank tests for the recurrence of bladder cancer in patients. (a) Th...

Recurrence and Progression Rate of High Grade Ta Bladder Cancer: 5-Year Follow up Results

Muhammet Kilinc

March 2014

Aim: The aim of the present study to evaluate recurrence and progression rates and success of BCG th...

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer - Fig 1

Bum Sik Tae (4688254)
Chang Wook Jeong (423166)
Cheol Kwak (474070)
Hyeon Hoe Kim (474071)
Kyung Chul Moon (626525)
Ja Hyeon Ku (474072)

December 2017

(A) Kaplan-Meier curves of recurrence-free survival (RFS) in patients with stage T1 (green) and o...

Stratifying risk for multiple, recurrent, and large (≥3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer

Jungyo Suh
Jae Hyun Jung
Cheol Kwak
Hyeon Hoe Kim
Ja Hyeon Ku

July 2021

Purpose: The current stratification of risk groups regarding recurrence and progression of non-muscl...

Re-examination of the Natural History of High-grade T1 Bladder Cancer using a Large Contemporary Cohort

Daniel J. Canter
Louis M. Revenig
Zachary L. Smith
Ryan W. Dobbs
S. Bruce Malkowicz
Muta M. Issa
Thomas J. Guzzo

April 2014

IntroductionHigh-grade T1 (HGT1) bladder cancer represents a clinical challenge in that the urologis...

Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score

Marie Simon (6407015)
Pierre-Olivier Bosset (6407018)
Mathieu Rouanne (3497495)
Simone Benhamou (111834)
Camelia Radulescu (6407021)
Vincent Molinié (5651248)
Yann Neuzillet (111802)
Xavier Paoletti (111804)
Thierry Lebret (111837)

February 2019

AimTo assess the prognostic value of multiple recurrences on the risk of progression in a large coho...

Aspects of Recurrence and Progression in Ta/T1 Urinary Bladder Cancer

Jancke, Georg

January 2013

Aims: To evaluate different aspects of recurrence and, when appropriate, progression in primary Ta/T...

Baseline characteristics and the number of transurethral procedures during 2 and 5 years of follow-up for the cohort of non-muscle invasive bladder cancer (NMIBC) patients and their matched comparison cohort.

Lars Holmberg (73013)
Oskar Hagberg (5069237)
Christel Häggström (276145)
Truls Gårdmark (10099132)
Viveka Ströck (10099141)
Firas Aljabery (5594660)
Staffan Jahnson (10099135)
Abolfazl Hosseini (1370439)
Tomas Jerlström (10046416)
Amir Sherif (5474768)
Karin Söderkvist (11189729)
Anders Ullén (5997569)
Mats Enlund (13851132)
Fredrik Liedberg (39980)
Per-Uno Malmström (573918)

September 2022

Baseline characteristics and the number of transurethral procedures during 2 and 5 years of follow-u...

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer - Fig 3

Bum Sik Tae (4688254)
Chang Wook Jeong (423166)
Cheol Kwak (474070)
Hyeon Hoe Kim (474071)
Kyung Chul Moon (626525)
Ja Hyeon Ku (474072)

December 2017

(A) Kaplan-Meier curves of progression-free survival (RFS) in patients with intravesical treatmen...

Predicting recurrence and progression in non-muscle-invasive bladder cancer using European organization of research and treatment of cancer risk tables.

Ather, M Hammad
Zaidi, Masooma

July 2009

Introduction:We determined the recurrence and progression at 1 year in Patients with non-muscle-inva...

Cumulative incidence curves.

Abstract

Extracted data

Cumulative incidence curves.

Abstract

Extracted data

Related items

Related items